CHRONIC PROSTATITIS AND FIBROSIS OF PROSTATE. PREDISPOSING FACTORS FOR SURGICAL COMPLICATIONS
PDF

Як цитувати

Ciuhrii, C., Colța, A., Pleșacov, A., & Ghicavîi, V. (2021). CHRONIC PROSTATITIS AND FIBROSIS OF PROSTATE. PREDISPOSING FACTORS FOR SURGICAL COMPLICATIONS. InterConf, (46), 254-263. https://doi.org/10.51582/interconf.19-20.03.2021.025

Анотація

Prostatitis is an inflammatory process of the prostate, which continues to be considered one of the most common urological diseases in men under 45. Predisposing factors as trophic, microcirculatory and congestive disorders, contributes to the onset and development of the inflammatory process in the prostate and risk factors as urethral catheter, urethrocystoscopy, endoscopic surgery for infection and deterioration of the integrity of the urethral epithelium. The purpose of this study was to determine the impact of chronic inflammation and fibrosis of prostate on urodynamics and local prostatic microcirculation and to evaluate the efficacy of medicamentous treatment. In the study were included 58 patients (with pronounced clinical symptoms as dysuria, stranguria, nocturnal pollakuria 2-4 times per night and residual urine about 50ml) that followed a course of treatment with Adenosprosin 250 mg. According to the study results, we can outline that the level of microcirculation and urodynamics impairment indicates the level of prostate fibrosis. This process in chronic prostatitis is reversible by using antifibrotic and anti-inflammatory treatment supplemented with Adenoprosin 250 mg.

https://doi.org/10.51582/interconf.19-20.03.2021.025
PDF

Посилання

Bushman W. A., Jerde T. J. The role of prostate inflammation and fibrosis in lower urinary tract symptoms. Am J Physiol Renal Physiol. 2016; 311(4): F817–F821.

Cantiello F., Cicione A., Salonia A. et al. Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. Urology. 2013; 81(5):1018–1023.

Ghicavii V., Ciuhrii C., Ceban E., Dumbraveanu I. New Direction in the Treatment of Benign Prostate Hyperplasia Using Adenoprosin: Biologically Active Entomological Medicine In Urology, 2011, 78(3), OI10.1016/j.urology.2011.07.209 (IF - 1,18)

Gorbunova E.N., Davydova D.A., Krupin V.N. Chronic inflammation and fibrosis as risk factors for prostatic intraepithelial neoplasias and prostate cancer. Modern technology in medicine. 2011; 1:79–83.

Gordon M.K., Hahn R.A. Collagens. Cell Tissue Res. 2010; 339:247–257.

He Y., Zeng H.Z., Yu Y., Zhang J.S. et al. Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis. Environ Toxicol Pharmacol. 2017; 54:120–124.

Hu Y., Niu X., Wang G. et al. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model. Andrology. 2016;4(6):1209–1216. DOI: 10.1111/andr.12273.

Kadler K.E., Baldock C., Bella J., Boot-Handford R.P. Collagens at a glance. J Cell Sci. 2007; 120:1955–1958.

Ma J., Gharaee-Kermani M., Kunju L. et al. Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol. 2012; 188:1375–1381.

Neimark A.I., Kiptilov A.V., Lapiy G.A. Clinical and pathological features of chronic prostatitis in chemical production workers. Urology. 2015; 3:68–73.

Nickel J.C., Roehrborn C.G., O’Leary M.P. et al. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol. 2008; 54:1379–1384.

Rodriguez-Nieves J.A., Macoska J.A. Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol. 2013; 10(9):546–550.

Wight T.N., Potter-Perigo S. The extracellular matrix: an active or passive player in fibrosis? Am J Physiol Gastrointest Liver Physiol. 2011; 301: G950–955.

Wong L., Hutson P.R., Bushman W. Prostatic inflammation induces fibrosis in a mouse model of chronic bacterial infection. PLoS One. 2014; 9(6): e100770.

Wong L., Hutson P.R., Bushman W. Resolution of chronic bacterial-induced prostatic inflammation reverses established fibrosis. Prostate. 2015; 75(1):23–32.

Zaitsev A.V., Pushkar D. Yu., Khodyreva L.A., Dudareva A.A. Chronic bacterial prostatitis, urinary disorders in men and prostate fibrosis. Urology. 2016; 4:114–120.

Думбравяну И., Банов П., Ариан Ю., Тэнасе А. Применение энтомологических препаратов в комплексном лечении больных хроническим простатитом и эректильной дисфункцией. 18 Конгресс ассоциации андрологов России. Дагомыс 23-25 мая 2019.

Думбрэвяну И., Гикавый В., Чебан Е., Тэнасе А. Лечение доброкачественной гиперплазии предстательной железы и воспалительных процессов простаты препаратом Аденопросин. В: Андрология и генитиальная хирургия. 2010, 2, c. 136-137, ISNN 2070 -9781.

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.

Завантаження

Дані завантаження ще не доступні.

| Переглядів: 65 | Завантажень: 55 |